SG11201803268TA - Ethylene glycol ether of buprenorphine - Google Patents
Ethylene glycol ether of buprenorphineInfo
- Publication number
- SG11201803268TA SG11201803268TA SG11201803268TA SG11201803268TA SG11201803268TA SG 11201803268T A SG11201803268T A SG 11201803268TA SG 11201803268T A SG11201803268T A SG 11201803268TA SG 11201803268T A SG11201803268T A SG 11201803268TA SG 11201803268T A SG11201803268T A SG 11201803268TA
- Authority
- SG
- Singapore
- Prior art keywords
- buprenorphine
- ethylene glycol
- glycol ether
- ether
- ethylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562246211P | 2015-10-26 | 2015-10-26 | |
PCT/US2016/058594 WO2017074904A1 (en) | 2015-10-26 | 2016-10-25 | Ethylene glycol ether of buprenorphine |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201803268TA true SG11201803268TA (en) | 2018-05-30 |
Family
ID=58630692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201803268TA SG11201803268TA (en) | 2015-10-26 | 2016-10-25 | Ethylene glycol ether of buprenorphine |
Country Status (13)
Country | Link |
---|---|
US (1) | US20180305370A1 (en) |
EP (1) | EP3368038A4 (en) |
JP (1) | JP2018531955A (en) |
KR (1) | KR20180080248A (en) |
CN (1) | CN108289887A (en) |
AU (1) | AU2016344309A1 (en) |
CA (1) | CA3002082A1 (en) |
IL (1) | IL258764A (en) |
MA (1) | MA43130A (en) |
MX (1) | MX2018004835A (en) |
SG (1) | SG11201803268TA (en) |
TW (1) | TW201726132A (en) |
WO (1) | WO2017074904A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004039317A2 (en) * | 2002-10-25 | 2004-05-13 | Euro-Celtique S.A. | Analogs and prodrugs of buprenorphine |
GB0606124D0 (en) * | 2006-03-28 | 2006-05-03 | Reckitt Benckiser Healthcare | Buprenorphine derivatives and uses thereof |
EP2562177A3 (en) * | 2006-09-22 | 2013-04-10 | AllTranz Inc. | Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof |
US20110097395A1 (en) * | 2008-03-08 | 2011-04-28 | Najib Babul | Oral Pharmaceutical Compositions of Buprenorphine and Method of Use |
KR20150027315A (en) * | 2010-09-21 | 2015-03-11 | 퍼듀 퍼머 엘피 | Buprenorphine analogs |
HUE040284T2 (en) * | 2011-10-03 | 2019-02-28 | Johnson Matthey Plc | Process for preparing buprenorphine |
-
2016
- 2016-10-25 EP EP16860598.8A patent/EP3368038A4/en not_active Withdrawn
- 2016-10-25 MX MX2018004835A patent/MX2018004835A/en unknown
- 2016-10-25 CA CA3002082A patent/CA3002082A1/en not_active Abandoned
- 2016-10-25 AU AU2016344309A patent/AU2016344309A1/en not_active Abandoned
- 2016-10-25 US US15/767,320 patent/US20180305370A1/en not_active Abandoned
- 2016-10-25 JP JP2018521221A patent/JP2018531955A/en active Pending
- 2016-10-25 MA MA043130A patent/MA43130A/en unknown
- 2016-10-25 SG SG11201803268TA patent/SG11201803268TA/en unknown
- 2016-10-25 WO PCT/US2016/058594 patent/WO2017074904A1/en active Application Filing
- 2016-10-25 KR KR1020187014752A patent/KR20180080248A/en unknown
- 2016-10-25 CN CN201680062566.4A patent/CN108289887A/en active Pending
- 2016-10-26 TW TW105134628A patent/TW201726132A/en unknown
-
2018
- 2018-04-17 IL IL258764A patent/IL258764A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL258764A (en) | 2018-06-28 |
KR20180080248A (en) | 2018-07-11 |
TW201726132A (en) | 2017-08-01 |
CA3002082A1 (en) | 2017-05-04 |
US20180305370A1 (en) | 2018-10-25 |
JP2018531955A (en) | 2018-11-01 |
EP3368038A4 (en) | 2019-04-10 |
MX2018004835A (en) | 2018-08-01 |
AU2016344309A1 (en) | 2018-05-17 |
EP3368038A1 (en) | 2018-09-05 |
WO2017074904A1 (en) | 2017-05-04 |
MA43130A (en) | 2018-09-05 |
CN108289887A (en) | 2018-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2545368B (en) | Diversion-resistant opioid formulations | |
ZA201608381B (en) | Process for the preparation of ethylene glycol from sugars | |
IL249663A0 (en) | Process for the preparation of substituted oxiranes and triazoles | |
GB201514993D0 (en) | Retractable table | |
ZA201608518B (en) | Process for the preparation of ethylene glycol from sugars | |
PL3199512T3 (en) | Method for preparing ethylene glycol | |
EP3005144A4 (en) | Search result ranker | |
ZA201708004B (en) | Ether compounds and related compositions | |
SG11201706544SA (en) | Breast shield | |
HK1252614A1 (en) | Bicyclic compounds | |
GB201509875D0 (en) | Annular cutter | |
HK1243341A1 (en) | Reduced foaming vaccine compositions | |
EP3134377A4 (en) | Improved process of making bioderived propylene glycol | |
GB201420512D0 (en) | Shield | |
ZA201704703B (en) | Method for preparing double end-capped ethylene glycol ether | |
EP3497076A4 (en) | Glycol ether process | |
IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
IL248999A0 (en) | Method of geolocation | |
TWM533567U (en) | Structure improvement of cutting machine | |
HUE043822T2 (en) | Method for the preparation of glycols | |
PT3391795T (en) | Compact suction station | |
IL258764A (en) | Ethylene glycol ether of buprenorphine | |
EP3368013C0 (en) | Liquid buprenorphine formulations | |
SG11201701258QA (en) | Collet | |
GB2544115B (en) | Cutter |